Citius Oncology, Inc. (CTOR) earnings
Quarterly results of Citius Oncology, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Citius Oncology, Inc. is expected to report around December 22, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended June 30, 2026) Citius Oncology, Inc. reported revenue of $1.5M and a net loss of $8.9M.
Diluted earnings per share were -$0.08.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | $1.5M | - | -$8.9M | -$0.08 |
| Q2 FY2026 | $1.7M | - | -$26.6M | -$0.27 |
| Q1 FY2026 | $3.9M | - | -$5.5M | -$0.06 |
| Q4 FY2025 | - | - | -$5M | - |
| Q3 FY2025 | - | - | -$5.4M | -$0.08 |
| Q2 FY2025 | - | - | -$7.7M | -$0.11 |
| Q1 FY2025 | - | - | -$6.7M | -$0.09 |
| Q4 FY2024 | - | - | -$6.8M | - |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly results 8-K
- Quarterly report 10-Q
When is Citius Oncology, Inc.'s next earnings date?
Citius Oncology, Inc. is expected to report around December 22, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were Citius Oncology, Inc.'s latest quarterly results?
For Q3 FY2026, which ended June 30, 2026, Citius Oncology, Inc. reported revenue of $1.5M and a net loss of $8.9M. The figures come from its filing with the SEC.
Get an email when CTOR reports
Follow CTOR and we email you its next results the day they are filed, with the numbers explained.